Oocyte vitrification for fertility preservation in women with endometriosis: an observational study

Ana Cobo, Cobo A, Giles J, Juan Gilés, Juan Giles, Stefania Paolelli, Paolelli S, António Pellicer, Pellicer A, Antonio Pellicer, José Remohí, Remohí J, José Remohı́, Juan A. García-Velasco, García-Velasco JA, Juan Antonio García-Velasco
Fertility and sterility · 2020 · vol. 113(4) , pp. 836–844 · doi:10.1016/j.fertnstert.2019.11.017 · PMID:32145929 · W3009383547
article OA: closed CC0 ⤵ 69 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-06 ⓘ

This observational study evaluated the efficacy of oocyte vitrification as a fertility preservation strategy for women diagnosed with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo describe the outcome of fertility preservation (FP) using vitrified oocytes in patients with endometriosis and to determine the impact of ovarian surgery.DesignRetrospective observational study.SettingUniversity-affiliated private in vitro fertilization (IVF) center.Patient(s)Four hundred and eighty-five women with endometriosis who underwent FP from January 2007 to July 2018.Intervention(s)Vitrification of metaphase II (MII) oocytes for future use.Main outcome measure(s)Oocyte survival rate and cumulative live-birth rate (CLBR).Result(s)Mean age at vitrification was 35.7 ± 3.7 years. The women undergoing operations were younger than the nonsurgical patients (33.4 ± 3.6 years vs. 36.7 ± 3.7 years). The survival rate and CLBR were 83.2% and 46.4%, respectively. The number of vitrified oocytes per cycle (6.2 ± 5.8) was higher for the nonsurgical patients compared with the unilateral (5.0 ± 4.5) or bilateral (4.5 ± 4.4) surgery groups, but was comparable among the surgical patients. The effect of age (adjusted odds ratio [OR] 0.904; 95% CI, 0.858-0.952), number of oocytes (adjusted OR 1.050; 95% CI, 1.025-1.091), and survival (adjusted OR 1.011; 95% CI, 1.001-1.020) on the CLBR was confirmed. However, the effect of surgery was not observed (adjusted OR 1.142; 95% CI, 0.778-1.677). Nonetheless, the ovarian response (vitrified oocytes = 8.6 ± 6.9 vs. 5.1 ± 4.8) and CLBR (72.5% vs. 52.8%) were higher in young (≤35 years) nonsurgical patient versus the surgical patients; older women showed similar outcomes.Conclusion(s)Fertility preservation gives patients with endometriosis a valid treatment option to help them increase their reproductive chances. We suggest performing surgery after ovarian stimulation for FP in young women. In older women, an individualized treatment should be considered.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Fertility Preservation Oocyte Retrieval Oocytes Vitrification Adult Endometriosis Endometriosis Female Fertility Preservation Humans Infertility, Female Infertility, Female Infertility, Female Oocyte Retrieval Oocytes Pregnancy Retrospective Studies

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (52)

Cited by (50)

Source provenance

europepmc
last seen: 2026-08-03T06:10:56.557307+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:22:11.167363+00:00
unpaywall
last seen: 2026-08-03T06:41:53.707437+00:00
License: CC0 · commercial use OK